KDM5A is found to be upregulated in the DTCs from EGFR‐mutant NSCLC cells; therefore, DTCs may be eradicated using EGFR TKI in combination with a HDAC inhibitor or a KDM5A inhibitor.44, 140. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.